Rinvoq 30 mg, Retardtabletten
7680672570037
CH-67257
Tabletten
Associated product:
RINVOQ comprimé à libération prolong. 30 mg 28 pce
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 28
- Selling units
- 28
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
upadacitinibum
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
upadacitinibum hemihydricum
|
- | Substance | WIZUS |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
acidum tartaricum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 848.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2024
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 67257
- Drug name
- Rinvoq, Retardtabletten
- Galenic form
- RETT
- ATC Code
- L04AF03
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 20/01/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- RINVOQ comprimé à libération prolong. 30 mg 28 pce
- Description (DE)
- RINVOQ Retardtabletten 30 mg 28 Stk
- Market launch
- 07/06/2024
- Narcotic (BTM)
- No